EICHOR
● Active Not Recruiting
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
Condition: Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation · Sponsor: Taiho Oncology, Inc.
About this study
The purpose of this study is to evaluate the safety and efficacy of zipalertinib in combination with standard first-line platinum-based chemotherapy compared to chemotherapy alone, in patients with locally advanced or metastatic NSCLC with EGFR ex20ins mutations.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (130)
| Comprehensive Cancer Centers of Nevada - Henderson | Henderson, Nevada, United States | — |
| Comprehensive Cancer Centers of Nevada - Horizon Ridge Henderson | Henderson, Nevada, United States | — |
| Comprehensive Cancer Centers of Nevada - Southeast Henderson - Stephanie | Henderson, Nevada, United States | — |
| Comprehensive Cancer Centers of Nevada - Summerlin Medical Center II | Las Vegas, Nevada, United States | — |
| Comprehensive Cancer Centers of Nevada - Southwest | Las Vegas, Nevada, United States | — |
| Comprehensive Cancer Centers of Nevada - Central Valley - Twain | Las Vegas, Nevada, United States | — |
| Comprehensive Cancer Centers of Nevada - Northwest | Las Vegas, Nevada, United States | — |
| Gabrail Cancer and Research Center | Canton, Ohio, United States | — |
| University of Texas MD Anderson Cancer Center | Houston, Texas, United States | — |
| Universitair Ziekenhuis Leuven - Campus Gasthuisberg | Leuven, Flemish Brabant, Belgium | — |
| Algemeen Ziekenhuis Maria Middelares | Ghent, Oost-Vlaaderen, Belgium | — |
| Algemeen Ziekenhuis Delta - Campus Menen | Menen, West Flanders, Belgium | — |
+ 118 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05973773